These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1789901)

  • 1. In vitro activity and cross resistance studies with cefpodoxime.
    Grimm H
    Zentralbl Bakteriol; 1991 Dec; 276(1):54-62. PubMed ID: 1789901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
    Knothe H; Shah PM; Eckardt O
    Infection; 1991; 19(5):370-6. PubMed ID: 1800379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
    Westblom TU; Gudipati S; Midkiff BR
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):691-3. PubMed ID: 2226500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Infection; 1991; 19(5):363-9. PubMed ID: 1800378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A; Jungwirth R
    Infection; 1991; 19(5):353-62. PubMed ID: 1800377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2902-4. PubMed ID: 7695280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
    Knapp CC; Sierra-Madero J; Washington JA
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1896-8. PubMed ID: 3245701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Hamilton-Miller JM; Brumfitt W
    Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of cefixime versus ceftizoxime against Salmonella typhi.
    Rastegar Lari A; Validi N; Ghaffarzadeh K; Shamshiri AR
    Pathol Biol (Paris); 1997 May; 45(5):415-9. PubMed ID: 9296095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological evaluation of cefpodoxime proxetil.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Drugs; 1991; 42 Suppl 3():6-12. PubMed ID: 1726210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.
    Kayser FH
    Infection; 1994; 22(5):370-5. PubMed ID: 7843823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R; Andrews JM; Ashby JP; Thornber D
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
    Cornaglia G; Ligozzi M; Bauernfeind A; Satta G; Fontana R
    New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefpodoxime: comparable evaluation with other orally available cephalosporins. With a note on the role of beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol; 1990 Sep; 273(4):501-17. PubMed ID: 2248685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cefpodoxime susceptibility with cephalothin and cefuroxime for urinary tract isolates.
    Bookstaver DA; Bland CM; Woodberry MW; Mansell KB
    J Med Microbiol; 2014 Feb; 63(Pt 2):218-221. PubMed ID: 24214230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
    Goldstein FW
    Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Apr; 45(4):359-63. PubMed ID: 1518118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.